Opthea (ASX:OPT) EPS (Basic) : A$-0.45 (TTM As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Opthea EPS (Basic)?

Opthea's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was A$-0.24. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.45.

Opthea's EPS (Diluted) for the six months ended in Dec. 2023 was A$-0.24. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.45.

Opthea's EPS without NRI for the six months ended in Dec. 2023 was A$-0.24. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.44.

During the past 3 years, the average EPS without NRI Growth Rate was -99.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -48.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was -18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Opthea's highest 3-Year average EPS without NRI Growth Rate was 27.40% per year. The lowest was -124.10% per year. And the median was -17.90% per year.

Opthea EPS (Basic) Historical Data

The historical data trend for Opthea's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opthea EPS (Basic) Chart

Opthea Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EPS (Basic)

Get a 7-Day Free Trial

-0.09

-0.06

-0.17

-0.35

-0.45

Opthea Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.14	-0.21	-0.25	-0.21	-0.24

Opthea EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Opthea's Basic EPS for the fiscal year that ended in Jun. 2023 is calculated as

Basic EPS (A: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-212.356	-	0)	/	469.557
	=	-0.45

Opthea's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-143.7	-	0)	/	592.640
	=	-0.24

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.45

Opthea (ASX:OPT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Opthea EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Opthea's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Opthea (ASX:OPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (ASX:OPT) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

OPT:USA UKJ:Germany

Address

650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141

Website

https://www.opthea.com

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.